Navigation Links
Trillium expands immunology pipeline and enters stem cell field through in-licensing of two new programs
Date:3/11/2010

TORONTO, March 11 /PRNewswire/ - Trillium Therapeutics Inc. (TTI), a biopharmaceutical company developing innovative immune-based biologics, today announced that it has entered into two definitive license agreements with University Health Network (UHN) and The Hospital for Sick Children (SickKids) in Toronto, Ontario, granting Trillium exclusive worldwide rights to commercialize two immunology programs in the areas of hematopoietic stem cell transplantation and cancer.

"We are very excited to have strengthened our immunology franchise and to have reinforced our existing bond with Toronto's world-class immunology community. Our productive long-standing relationship with UHN bodes well for the success of this new collaboration", commented Dr. Niclas Stiernholm, Trillium's CEO. "This transaction exemplifies how ground-breaking Canadian science can and should be commercialized by our domestic biotechnology industry, something that must be encouraged and supported also by government and investor groups."

The first project licensed by TTI is aimed at improving hematopoietic stem cell engraftment by agonizing a key immunoregulatory pathway and thereby preventing the host immune system from attacking transplanted stem cells. The second program is focused on the treatment of several types of cancers by antagonizing the same pathway in cancer stem cells, stimulating the patient's own im
'/>"/>

SOURCE Trillium Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Trillium adds industry veteran Dr. Mike Gresser to its Board of Directors
2. Trillium and Biogen Idec enter into global license agreement
3. Trillium Strengthens its Board of Directors
4. Trillium secures additional financing on the strength of lead program and proprietary position around the CD200 immunoregulatory pathway
5. Epeius Biotechnologies Corporation Expands its Rexin-G Production Facilities in Southern California
6. BioMed Realty Trust Expands Lease With Ironwood Pharmaceuticals for 50,000 Square Feet in Cambridge, Massachusetts
7. Laboratory Products Leader Sterlitech Expands RO Membranes Line
8. Glycos Biotechnologies Expands Management Team with Appointment of Vice President of Research and Development
9. Progenitor Cell Therapy Expands Manufacturing Operations
10. Karolinska Development Expands its Life Science Portfolio With BioChromix Pharma
11. Wound Management Technologies, Inc. Rapidly Expands Its International Presence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Interventional cardiologist Tony Farah, MD, and his ... Cardiovascular Institute have helped pioneer many breakthroughs in ... over the past three decades, from new disease-fighting medications ... artery stent implantation. , Today, AGH officials announced that ... in the study of a novel, first-of-its kind investigational ...
(Date:5/20/2013)... 20, 2013 Kitware, a leader in ... that enables the exploration of hospital costs across ... response to the recent release of “Medicare Provider Charge ... 100 most-billed procedures from the Centers for Medicare & ... similar procedures at hospitals across the country has sparked ...
(Date:5/19/2013)... The JM Internet Group (web: jm-seo.org), a leader ... that the company's YouTube channel on SEO tips ... YouTube. The company uses YouTube as a way to ... for small businesses with much success. , "I love ... for their SEO strategies", explained Jason McDonald, director of ...
(Date:5/17/2013)... occurs when the transplant recipient,s immune system identifies the ... was previously thought that T cells, the immune cells ... known as chemokines in order to migrate to the ... of Clinical Investigation , Fadi Lakkis and colleagues at ... chemokine stimulation of T cells is not required for ...
Breaking Biology Technology:Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4Kitware Enables Interactive Exploration of CMS Medicare Data 2YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2
... Lilly and Company,strongly objects to implications in a New ... results of negative clinical,trials., The story, based on ... (NEJM), cited Prozac and Lilly as high-profile examples of ... only was,the Times, story inaccurate when it comes to ...
... Collected on myLifetime.com in ... Protection Act Allows Women Choice to, Recuperate for at Least 48 ... ... -, NEW YORK, Jan. 18 "Desperate Housewives",star Marcia Cross will ...
... Corporation today,announced the appointment of Wendy Perrow, as ... Ms. Perrow will be responsible for,leading Alba,s marketing ... commercialization. Ms. Perrow will also serve as a,member ... are very pleased to announce that Ms. Perrow ...
Cached Biology Technology:In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 2In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 3In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement: 4Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hill Press Conference 2Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross to Join Lifetime Networks and Members of Congress From Both Parties at Capitol Hill Press Conference 3Alba Therapeutics Appoints Wendy Perrow as its Vice President, Marketing and Alliance Management 2
(Date:5/18/2013)... 18, 2013) An increasing number of U.S. ... to resolve, according to research presented at Digestive ... targeting obesity, researchers at the Cleveland Clinic Children,s ... pattern of exhaled breath compared to their lean ... compound levels that can be correlated to potential ...
(Date:5/17/2013)... group of proteins in the brain responsible for protecting ... that could increase cell survival. , The discovery, made ... published in the EMBO journal with additional ... therapies for stroke and other brain diseases. , The ... identified a protein, known as SUMO, responsible for controlling ...
(Date:5/17/2013)... An international team of scientists using a new X-ray ... a living frog embryo in greater detail than ever ... biological research and the search for new treatments for ... Institut fr Technologie in Germany, in collaboration with the ... Argonne National Laboratory, released the most precise depiction ever ...
Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3SUMO wrestling cells reveal new protective mechanism target for stroke 2New X-ray method shows how frog embryos could help thwart disease 2
... Delbrck Center for Molecular Medicine (MDC) Berlin-Buch have discovered ... cell types and thus to be pluripotent. This pluripotency ... primarily known for its role in mediating cell-cell adhesion ... absent, the stem cells lose their pluripotency. The molecule ...
... A bacteria which infects people with cystic fibrosis ... team from Cardiff and Warwick Universities. Continuous use ... causing major health problems all over the world. New ... multidrug-resistant bacteria such as the MRSA superbug. ...
... Results of a study, involving 98,454 patients demonstrated that ... patients were approximately 20% less likely to be prescribed ... to healthy patients. These finding remained relatively unchanged at ... with a high number being prescribed the current standards ...
Cached Biology News:MDC researchers discover key molecule for stem cell pluripotency 2Cystic fibrosis bacteria could help fight back against antibiotic resistance 2Undertreatment of cardiovascular disease in rheumatoid arthritis patients following a heart attack 2
Required to perform reference file generation, flatfield calibration and performance verification processes on the GSD-501...
... TempliPhi 100 Amplification Kit, 100 reactions. ... sequencing in 4-6 h.Generate microgram quantities ... of starting material.Use amplified DNA directly ... from bacterial or M13 liquid cultures, ...
... Rack inserts fit into the ... allow you to greatly increase ... deepwell format plates at an ... from the shaker at once ...
BD FastImmune EDTA Solution. Applications: Flow Cytometry Storage Temperature: Refrigerate(2 to 8C)...
Biology Products: